Trial Profile
Influence of catechol-O-methyltransferase polymorphism on entacapone efficacy in Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Entacapone (Primary) ; Levodopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacogenomic; Therapeutic Use
- 04 May 2010 Actual patient number (60) added as reported by ClinicalTrials.gov.
- 04 May 2010 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 04 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.